Ligand-based drug repurposing strategy identified SARS-CoV-2 RNA G-quadruplex binders
Lupia A.;
2022-01-01
Abstract
The single-stranded RNA genome of SARS-CoV-2 contains some G-quadruplex-forming G-rich elements which are putative drug targets. Here, we performed a ligand-based pharmacophore virtual screening of FDA approved drugs to find candidates targeting such RNA structures. Further in silico and in vitro assays identified three drugs as emerging SARS-CoV-2 RNA G-quadruplex binders.File | Size | Format | |
---|---|---|---|
pub_012.pdf open access
Type: versione editoriale
Size 1.8 MB
Format Adobe PDF
|
1.8 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.